Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · IEX Real-Time Price · USD
2.810
-0.270 (-8.77%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Myomo Revenue

Myomo had revenue of $19.55M in the twelve months ending March 31, 2024, with 29.17% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.75M with 8.93% year-over-year growth. In the year 2023, Myomo had annual revenue of $19.24M with 23.70% growth.

Revenue (ttm)
$19.55M
Revenue Growth
+29.17%
P/S Ratio
4.14
Revenue / Employee
$193,553
Employees
101
Market Cap
80.97M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202319.24M3.69M23.70%
Dec 31, 202215.56M1.70M12.26%
Dec 31, 202113.86M6.27M82.72%
Dec 31, 20207.58M3.75M97.60%
Dec 31, 20193.84M1.39M57.02%
Dec 31, 20182.44M885.24K56.79%
Dec 31, 20171.56M455.59K41.29%
Dec 31, 20161.10M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Protalix BioTherapeutics 59.65M
SHL Telemedicine 57.08M
Eton Pharmaceuticals 35.30M
Forian 20.49M
Asensus Surgical 8.72M
Cardiff Oncology 610.00K
Revenue Rankings